Malignant Pleural Mesothelioma: What Do Clinical Trials Suggest on Angiokinase Inhibitors, Immunotherapy Options, and Combination Strategies?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

0:00

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

Malignant Pleural Mesothelioma: What Do Clinical Trials Suggest on Angiokinase Inhibitors, Immunotherapy Options, and Combination Strategies?

By Memorial Sloan Kettering Cancer Center FEATURING Marjorie Zauderer

0 views

May 25, 2020

Comments 0

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

Feat. B. Halmos